EUVIMEDEUVIMED entdecken
Open Access

Omission of Axillary Dissection in Node Positive Breast Cancer After Neoadjuvant Systemic Therapy

Gray B Peery, Joyce Pak, Laura Burkbauer, Chris B Agala, Julia M Selfridge, Kristalyn K Gallagher, Philip M Spanheimer

Journal of Surgical Research · 2023

DOI: 10.1016/j.jss.2023.08.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Research, 2023. Verfasst von Gray B Peery und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of North Carolina, Chapel Hill, North Carolina. Hauptthemen laut MEDLINE: Breast Neoplasms, Neoadjuvant Therapy, Lymph Node Excision, Axilla. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, National Institutes of Health, NCI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Guidelines recommend axillary lymph node dissection (ALND) for ypN + positive patients as patients receiving neoadjuvant systemic therapy (NST) were excluded from trials omitting ALND in pN + patients. We sought to characterize trends in omission of ALND in patients with ypN + disease. METHODS: Adult women with invasive breast carcinoma in the National Cancer Database between 2012 and 2019 who received NST (chemotherapy or endocrine) and had ypN + disease were included. Patients were excluded if they did not have definitive surgery within eight months of diagnosis. The primary study outcome was completion of ALND versus omission. Differences in demographics, tumor characteristics, and treatment were identified using bivariate and multivariate logistic regression models. RESULTS: In total, 103,121 women were included. Most had cT1 (26%) or cT2 (45%) tumors, cN + disease (71%), and ductal histology (83%). 69% of patients received neoadjuvant chemotherapy and 31% neoadjuvant endocrine without chemotherapy (30% both). ALND was performed in 77% of patients. Omission of ALND became more prevalent each year from 2012 (14%) to 2019 (34%). On multivariate modeling, year of diagnosis, black race, cN status, higher grade, estrogen receptor+/HER2-receptor subtype, and mastectomy were associated with increased prevalence of ALND. Age, Charlson/Deyo comorbidity index score, endocrine versus chemotherapy, and adjuvant radiation were not associated with receipt of ALND. CONCLUSIONS: Despite guidelines recommending ALND, omission is common in patients with ypN + breast cancer after NST. Omission of ALND increased significantly over time and is associated with clinical and demographic factors. Future study is needed to determine the oncologic safety of this approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsNeoadjuvant TherapyLymph Node ExcisionAxillaHumansFemaleMiddle AgedAgedAdultRetrospective StudiesChemotherapy, AdjuvantLymphatic MetastasisLymph NodesMastectomyNeoplasm Staging

Stichwörter der Autor:innen

Axillary lymph node dissectionBreast cancerNeoadjuvant chemotherapyNeoadjuvant endocrine therapy

Autor:innen und Institutionen

  • Department of Surgery, University of North Carolina, Chapel Hill, North Carolina.
  • Department of Epidemiology, University of North Carolina, Chapel Hill, North Carolina.
  • Department of Surgery, University of North Carolina, Chapel Hill, North Carolina. Electronic address: Philip_Spanheimer@med.unc.edu.

Förderung

  • NCI NIH HHS
  • National Institutes of Health
  • NCI

Zitieren

APA

Peery, G. B., Pak, J., Burkbauer, L., Agala, C. B., Selfridge, J. M., Gallagher, K. K., & Spanheimer, P. M. (2023). Omission of Axillary Dissection in Node Positive Breast Cancer After Neoadjuvant Systemic Therapy. Journal of Surgical Research. https://doi.org/10.1016/j.jss.2023.08.004

Vancouver

Peery GB, Pak J, Burkbauer L, Agala CB, Selfridge JM, Gallagher KK, et al. Omission of Axillary Dissection in Node Positive Breast Cancer After Neoadjuvant Systemic Therapy. Journal of Surgical Research. 2023. doi:10.1016/j.jss.2023.08.004

BibTeX
@article{Peery2023,
  author = {Peery, Gray B and Pak, Joyce and Burkbauer, Laura and Agala, Chris B and Selfridge, Julia M and Gallagher, Kristalyn K and Spanheimer, Philip M},
  title = {Omission of Axillary Dissection in Node Positive Breast Cancer After Neoadjuvant Systemic Therapy},
  journal = {Journal of Surgical Research},
  year = {2023},
  doi = {10.1016/j.jss.2023.08.004}
}
Kostenlos starten →